Skip to content
healthcare.dev
Get a free key

Levocetirizine Dihydrochloride

NDC 10135-639, levocetirizine Dihydrochloride, tablet, film coated, from Marlex Pharmaceuticals Inc.

Product NDC
10135-639
Status
Listed
Labeler
Marlex Pharmaceuticals Inc
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA202046
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/10135-639 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LEVOCETIRIZINE DIHYDROCHLORIDE5 mg/1

Pharmacologic classes

Histamine H1 Receptor Antagonists [MoA]; Histamine-1 Receptor Antagonist [EPC]

Package NDCNDC-11Package
10135-639-301013506393030 TABLET, FILM COATED in 1 BOTTLE (10135-639-30)
10135-639-901013506399090 TABLET, FILM COATED in 1 BOTTLE (10135-639-90)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/f5d8d6a6-6455-430b-8923-090e1ca2ae3b

Use it

Look up 10135-639 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/10135-639 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 10135-639. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.